- Operational corporate management, including strategic, innovation, human resources, stakeholder, interface, service and quality management, marketing, sales and public relations - Experience in business analysis and valuation- Ensuring efficient monitoring and reporting- Implementing sustainable measures to achieve all short, medium and long-term corporate goals - Continuous process optimisation to improve workflows, including digitalisation- Collaboration with committees, authorities, business partners and shareholders- Management of digital & analogue donor and customer acquisition - Network maintenance in the industry, politics and with administrations, representation of the company- Development of guidelines for corporate culture and vision

- Acquisition of more than 15 million euros as funding from investors, EU, federal and local government for the implementation of the LXP business model as a know-how provider and for the necessary research and development tasks- Development and ongoing improvement of the LXP business model including technical and economic milestones necessary for success- Company development including implementation of verifiable measures to achieve all short, medium and long-term corporate goals in close coordination with management team, shareholders and advisory board- Strategic focus on the core markets: short-term target geared towards biogas and bio-ethanol and medium to long-term geared towards bio-based chemicals- Financial management and monitoring of P&L account the statements of changes in equity and cash flows, current business and the development of costs- Experience in business analysis and valuation- Combined chemical, biotechnological and disposal expertise for municipal, agricultural and forestry waste to differentiate itself from the competition - Lead the team to develop viable licensing and financial modelling concepts, the IP strategy including FTO analysis and monitoring of competitors with the benefit of expert advice- Development of the corporate identity of LXP and maxbiogas GmbH (LXP subsidiary)- Built a pipeline of more than 20 potential licensees in Europe for different markets (biogas, bioethanol, biochemicals made from sugars and biochemicals made from lignin), some of them by negotiating exclusive MOUs- Contract negotiations, including letters of intent, cooperation and license agreements, etc. - Presentation of the LXP on the company's website, at investor events, conferences and industry fairs, in articles, on posters, in press releases, flyers, films, interviews or in the annual newsletter - Interacting with governmental stake holders, associations, research institutes, etc.- Supporting start-up companies as a mentor

maxbiogas GmbH is a subsidiary of LXP Group GmbH. The company was founded to commercialize the LXP technology in the biogas market.

- Management of the scientific, research and technological operations of the company - Key advisor to the CEO in strategic R&D decisions- Supervision of IP portfolio- Development of medical products, including lead product development of the CellCollector®, the world's first in vivo CTC insulation product with CE approval- Development of risk-benefit analysis in the context of procedures for clinical approval of medical devices- Support and preparation of clinical studies- Introduction and application of a quality management system for medical devices - Establishment of cooperation networks and acquisition of funding- Public relations functions by representing the scientific goals and interests of the company at press conferences, meetings, conventions and shareholder events

- Personal responsibility for development of new and innovative bioanalytical tests for a medical laboratory- Support and collaboration in a clinical study